a year ago
CABA
AnalystsSamantha SemenkowSamantha Semenkow's Stock Forecasts
AnalystsSamantha Semenkow
Sectors:
Analyst Ranking
Bottom 2%
#4801 out of 4868 analysts
Average Return
-18.34%
Win Rate
29%10 out of 35
Risk vs Reward
Poor
Good
Samantha Semenkow's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Morphic Holding IncMORF | +109.75% | $27.17 | $56.99 | 2023-12-08 - 2024-08-16 | Strong Buy |
Larimar Therapeutics IncLRMR | +103.34% | $3.29 | $6.69 | 2023-11-17 - 2024-11-15 | Strong Buy |
Immunovant IncIMVT | +78.11% | $16.17 | $28.80 | 2023-04-25 - 2024-04-24 | Strong Buy |
Argenx SeARGX | +40.99% | $435.92 | $614.59 | 2023-11-29 - 2024-11-27 | Strong Buy |
Catalyst Pharmaceuticals IncCPRX | +31.44% | $18.48 | $24.29 | 2024-08-09 - 2025-04-30 | Strong Buy |
Samantha Semenkow Analyst Color
Get additional color on Samantha Semenkow's coverage of popular stocks
a year ago
EDIT
a year ago
LRMR
Samantha Semenkow's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Argenx SeARGX | 5 | Strong Buy | $796.00 | +23.38% | Maintains | 14 days ago |
Bioage Labs IncBIOA | 3 | Hold | $5.00 | +19.05% | Maintains | a month ago |
Acelyrin IncSLRN | 2 | Hold | $3.00 | +21.46% | Maintains | 4 months ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $12.00 | +237.08% | Initiates Coverage On | 5 months ago |
Allogene Therapeutics IncALLO | 2 | Strong Buy | $8.00 | +376.19% | Maintains | 9 months ago |
Catalyst Pharmaceuticals IncCPRX | 2 | Strong Buy | $31.00 | +27.62% | Maintains | 9 months ago |
Sana Biotechnology IncSANA | 2 | Strong Buy | $15.00 | +689.47% | Maintains | 9 months ago |
Sensei Biotherapeutics IncSNSE | 2 | Strong Buy | $4.00 | +892.56% | Reinstates | a year ago |
Larimar Therapeutics IncLRMR | 6 | Strong Buy | $14.00 | +428.30% | Maintains | a year ago |
Prime Medicine IncPRME | 2 | Strong Buy | $10.00 | +478.03% | Upgrades | a year ago |
Editas Medicine IncEDIT | 4 | Strong Buy | $15.00 | +809.09% | Maintains | a year ago |
2seventy Bio IncTSVT | 2 | Strong Buy | $12.00 | N/A | Maintains | a year ago |
Cabaletta Bio IncCABA | 2 | Strong Buy | $30.00 | N/A | Maintains | a year ago |
Moonlake ImmunotherapeuticsMLTX | 1 | Strong Buy | $72.00 | N/A | Initiates Coverage On | a year ago |
Morphic Holding IncMORF | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | a year ago |
Immunovant IncIMVT | 3 | Strong Buy | $50.00 | N/A | Maintains | 2 years ago |
Beam Therapeutics IncBEAM | 3 | Strong Buy | $56.00 | N/A | Maintains | 2 years ago |
9 Meters Biopharma IncNMTRQ | 3 | Hold | $0.75 | N/A | Maintains | 2 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.